‘Patchy efforts’ by major insulin makers mean access lags in many poor countries

“The global inequity is so stark and current efforts still fall short for people living in LMICs (low- and middle-income countries) and I think we need to do something about this.”

In an article for STAT, Ed Silverman spoke to Jay K. Iyer, Chief Executive Officer, and Claudia Martínez, Research Programme Manager, about the Access to Medicine Foundation’s latest report on access to insulin, published on 6 October, 2022.